(Q37796814)

23 August 2017

1 reference

title

Anti-schizophrenic drugs--membrane receptor sites of action (English)

1 reference

23 August 2017

Anti-schizophrenic drugs—Membrane receptor sites of action (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

19 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

19 October 2022

P. Seeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20896

19 October 2022

language of work or name

English

0 references

publication date

1 October 1977

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:0006295277903409?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

https://api.elsevier.com/content/article/PII:0006295277903409?httpAccept=text/plain

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

19 October 2022

published in

Biochemical Pharmacology

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

1741-1748

1 reference

Clinical studies with dopamine-receptor stimulants

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Plasma protein binding of chlorpromazine

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Common Mode of Action of Three Agents that Decrease the Transient Change in Sodium Permeability in Nerves

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Studies of delayed-action medication V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

A noradrenaline sensitive adenylate cyclase in the rat limbic forebrain: Preparation, properties and the effects of agonists, adrenolytics and neuroleptic drugs

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Salivary excretion of amobarbital in man

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopamine Receptors in the Brain

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Tricyclic antidepressive drugs and dopamine-sensitive adenylate cyclase from rat brain striamtum

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Current biochemical approaches to schizophrenia

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The membrane concentraton of a local anesthetic (Chlorpromazine)

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Apomorphine and psychopathology

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Partition coefficients and their uses

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Serum levels of thioridazine in psychiatric patients and healthy volunteers

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopamine and the pharmacology of schizophrenia: the state of the evidence

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Biochemical aspects of schizophrenia

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Serum prolactin levels in unmedicated schizophrenic patients

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Dopaminergic neurons—Alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Oil-water partitioning of chlorpromazine and other phenothiazine derivatives using dodecane and n-octanol

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The pathogenesis of schizophrenia. Possible relationships between genetic, biochemical, and experiential factors.

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Presynaptic action of central depressant drugs: inhibition of depolarization-secretion coupling

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Comparative studies on the membrane actions of depressant drugs: the role of lipophilicity in inhibition of brain sodium and potassium-stimulated ATPase

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

THE SURFACE ACTIVITY OF TRANQUILIZERS

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Adsorption and conduction-block of opiate narcotics on nerve membranes: identical effects of levo- and dextro-forms

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Calcium Reversal of Nerve Blockade by Alcohols, Anesthetics, Tranquilizers, and Barbiturates

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

A New Prolonged-Acting Type of Chlorpromazine: Behavioral Effects and Prolonged Actions on Nerve Membranes

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Antipsychotic drug doses and neuroleptic/dopamine receptors

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Bioequivalency of generic and brand-named chlorpromazine.

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The Impulse-Blocking Concentrations of Anesthetics, Alcohols, Anticonvulsants, Barbiturates, and Narcotics on Phrenic and Sciatic Nerves

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

Displacement of bound 14C-fluphenazine by biogenic amines and antipsychotic drugs in homogenates of brain tissue

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum

19 October 2022

series ordinal

101

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

A gas chromatographic method for the determination of haloperidol in human plasma

19 October 2022

series ordinal

103

1 reference

https://api.crossref.org/works/10.1016/0006-2952(77)90340-9

19 October 2022

Identifiers

1 reference

23 August 2017

1 reference